Bente Lund

4.4k total citations
44 papers, 834 citations indexed

About

Bente Lund is a scholar working on Reproductive Medicine, Oncology and Surgery. According to data from OpenAlex, Bente Lund has authored 44 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Reproductive Medicine, 21 papers in Oncology and 7 papers in Surgery. Recurrent topics in Bente Lund's work include Ovarian cancer diagnosis and treatment (28 papers), PARP inhibition in cancer therapy (9 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). Bente Lund is often cited by papers focused on Ovarian cancer diagnosis and treatment (28 papers), PARP inhibition in cancer therapy (9 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). Bente Lund collaborates with scholars based in Denmark, United States and Sweden. Bente Lund's co-authors include Mansoor Raza Mirza, Svein Kristiansen, T. H. Blackburn, René dePont Christensen, Susanne Malander, Line Bjørge, Peter Williamson, Gabriel Lindahl, Henrik Roed and C G Moertel and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Bente Lund

41 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bente Lund Denmark	16	452	405	134	119	116	44	834
Hiroshi Sasaki Japan	17	372 0.8×	434 1.1×	440 3.3×	147 1.2×	450 3.9×	48	1.4k
Chaitanya R. Acharya United States	17	702 1.6×	317 0.8×	449 3.4×	75 0.6×	82 0.7×	42	1.8k
Fumio Yamasaki Japan	21	255 0.6×	113 0.3×	224 1.7×	181 1.5×	93 0.8×	66	1.1k
Barbara A. Ward United States	21	296 0.7×	78 0.2×	185 1.4×	400 3.4×	52 0.4×	51	1.5k
Angela Cheng Canada	17	149 0.3×	304 0.8×	130 1.0×	241 2.0×	403 3.5×	32	986
Yunguang Li China	16	164 0.4×	74 0.2×	343 2.6×	62 0.5×	59 0.5×	34	821
N. Vavra Austria	15	146 0.3×	346 0.9×	88 0.7×	193 1.6×	238 2.1×	80	668
M Moriyama Japan	11	210 0.5×	116 0.3×	520 3.9×	149 1.3×	99 0.9×	17	968
Elena Riccardi Italy	19	99 0.2×	109 0.3×	402 3.0×	130 1.1×	9 0.1×	32	953
Xiaoyun Wan China	18	113 0.3×	83 0.2×	639 4.8×	76 0.6×	118 1.0×	44	1.1k

Countries citing papers authored by Bente Lund

Since Specialization

Citations

This map shows the geographic impact of Bente Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bente Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bente Lund more than expected).

Fields of papers citing papers by Bente Lund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bente Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bente Lund. The network helps show where Bente Lund may publish in the future.

Co-authorship network of co-authors of Bente Lund

This figure shows the co-authorship network connecting the top 25 collaborators of Bente Lund. A scholar is included among the top collaborators of Bente Lund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bente Lund. Bente Lund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Coleman, Robert L., Domenica Lorusso, Christine Gennigens, et al.. (2020). LBA32 Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer: Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study. Annals of Oncology. 31. S1162–S1163. 17 indexed citations

Mirza, Mansoor Raza, Line Bjørge, Frederik Marmé, et al.. (2020). LBA28 A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial. Annals of Oncology. 31. S1160–S1160. 52 indexed citations

Mirza, Mansoor Raza, Bente Lund, René dePont Christensen, et al.. (2020). Final survival analysis of NSGO-AVANOVA2/ENGOT-OV24: Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer—A randomized controlled chemotherapy-free study.. Journal of Clinical Oncology. 38(15_suppl). 6012–6012. 13 indexed citations

Mirza, Mansoor Raza, Elisabeth Åvall Lundqvist, Michael J. Birrer, et al.. (2019). Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial. The Lancet Oncology. 20(10). 1409–1419. 187 indexed citations

Oza, Amit M., Ursula A. Matulonis, Susanne Malander, et al.. (2018). Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial. The Lancet Oncology. 19(8). 1117–1125. 87 indexed citations

Steffensen, Karina Dahl, Marianne Waldstrøm, Ivan Brandslund, et al.. (2016). Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer. Oncology Letters. 11(6). 3967–3974. 13 indexed citations

Vergote, Ignace, Bente Lund, Hanne Havsteen, et al.. (2016). Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers. Annals of Oncology. 27. vi296–vi296. 3 indexed citations

Lund, Bente, Hanne Havsteen, Tami Rashal, et al.. (2014). KCP-330-005/SIGN: A phase II, open-label study of efficacy and safety of the selective inhibitor of nuclear export (SINE) KPT-330 (SELINEXOR) in patients with advanced gynaecologic malignancies. International Journal of Gynecological Cancer. 29. 2 indexed citations

Wang, Yun, Jørn Herrstedt, Hanne Havsteen, et al.. (2014). A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer. BMC Cancer. 14(1). 937–937. 7 indexed citations

10.

Lund, Bente, et al.. (2013). Primært malignt melanom i vagina. VBN Forskningsportal (Aalborg Universitet). 175(3).

11.

Brundage, Michael, M. Gropp, F. Mefti, et al.. (2012). Health-related quality of life in recurrent platinum-sensitive ovarian cancer—results from the CALYPSO trial. Annals of Oncology. 23(8). 2020–2027. 30 indexed citations

12.

Steffensen, Karina Dahl, Marianne Waldstrøm, Bente Lund, et al.. (2012). Panitumumab and Pegylated Liposomal Doxorubicin in Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-Type. International Journal of Gynecological Cancer. 23(1). 73–80. 16 indexed citations

13.

Steffensen, Karina Dahl, et al.. (2011). Improved Classification of Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 21(9). 1592–1600. 31 indexed citations

14.

Mirza, Mansoor Raza, Bente Lund, Jacob Christian Lindegaard, et al.. (2010). A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin. Gynecologic Oncology. 119(1). 26–31. 8 indexed citations

15.

Jensen, Ingelise, et al.. (2010). Radiobiological Impact of Reduced Margins and Treatment Technique for Prostate Cancer in Terms of Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP). Medical dosimetry. 36(2). 130–137. 12 indexed citations

16.

Brundage, Michael, M. Gropp, F. Mefti, et al.. (2010). Health-related quality of life (HRQL) and progression-free survival (PFS) in patients with recurrent ovarian cancer: Results from the CALYPSO trial.. Journal of Clinical Oncology. 28(15_suppl). 5044–5044.

17.

Carl, Jesper, et al.. (2006). Automated detection of a prostate stent in electronic portal images. Medical Physics. 33(12). 4600–4605. 3 indexed citations

18.

Carl, Jesper, et al.. (2006). Feasibility study using a Ni–Ti stent and electronic portal imaging to localize the prostate during radiotherapy. Radiotherapy and Oncology. 78(2). 199–206. 16 indexed citations

19.

Tuxen, Malgorzata, Bente Lund, Ole Hansen, & M Hansen. (1993). Second-look laparotomy in the management of patients after radical surgery for ovarian cancer. Annals of Oncology. 4(2). 169–171. 3 indexed citations

20.

Lund, Bente, Morten Hansen, Finn Lundvall, et al.. (1989). Intestinal obstruction in patients with advanced carcinoma of the ovaries treated with combination chemotherapy.. PubMed. 169(3). 213–8. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact